John Wiley, the outgoing chancellor of the University of Wisconsin-Madison, will serve as director of the Wisconsin Institute for Discovery on an interim basis, beginning on Nov. 1, 2008. Wiley, who announced his retirement as chancellor earlier this year, will take over for Marsha Mailick...
Prodesse, is a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious diseases, has announced the international release of an assay used for the detection of the human metapneumovirus, a respiratory virus. The assay currently is available in the United States...
Biotech areas where Madison and Wisconsin have a significant presence advanced in terms of progress and commercial impact in 2007, according to a new study by Deloitte Consulting. The technologies that are on the rise - targeted therapies, monoclonal antibodies, radiotherapy, and drug-device combinations -...
With Wisconsin still trying to absorb recent events like the pending GM plant closing in Janesville and historic flooding, it's not a bad time to smell the roses - the biotech roses, according to columnist Tom Still. As Wisconsin biotech leaders prepare to invade the...
With an FDA submission in its future, Madison's EraGen Biosciences has hired a 20-year industry veteran with experience in regulatory strategy. Randal Vader will serve as vice president of quality, regulatory, and clinical affairs for the molecular diagnostics company. He comes to EraGen after serving...
Now that it has announced plans to build a 120,000-square-foot plant to expand its production of large-scale pharmaceutical ingredients, Cambridge Major Laboratories has added a business development director in Europe. The Germantown drug development company has appointed Roger McDonald, formerly of the British chemical and...
Third Wave Technologies of Madison does not anticipate significant workforce reductions as a result of its acquisition by Holigic Inc., according to a company spokesman. The two companies have entered into an agreement in which Hologic, based in Bedford, Mass., would acquire Third Wave for...
Third Wave Technologies' success in advancing tests for a virus linked to cervical cancer has prompted the Bedford, Mass.-based Hologic to acquire the Madison company for $580 million, or $11.25 per share. Hologic, which has an extensive sales and distribution network for its women's health...
Mithridion, Inc. of Madison and Cognitive Pharmaceuticals of Toledo, Ohio have agreed to merge to continue the development of Cognitive's new drug to treat Alzheimer's disease. In addition to sharing executive talent and technology, the merged life science firms also announced they have closed on...
Gov. Jim Doyle has announced that the World Stem Cell Summit will be launched where many boats are - Lake Mendota – with a Lab on the Lake forum and festival. The summit, set for Sept. 21-23 in Madison, is expected to attract premier researchers...